ENDRA Life Sciences Inc. ( NDRA) - Stock Earnings
NDRA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
NDRA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -3.2 million USD | — USD |
| 2026Q1 | -1.3 million USD | — USD |
| 2026Q2 | 159944 USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NDRA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.1 million USD | — USD |
| 2024 | -11.5 million USD | — USD |
| 2025 | -7.0 million USD | — USD |
| 2026 Est. | — | — |
NDRA
Price: $4.80
52 week price:
Earnings Per Share: -6.29 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 4700
Ebitda: -2.3 millionMarket Capitalization: 7.7 million